IL10 and neoplasm: Some cytokines [such as transforming growth factor beta (TGF-β), interleukin-10 (IL-10), and programmed death-ligand 1 (PD-L1)] are characterized by inhibiting immune cell activity and reducing the recognition and attack of tumor cells, thereby facilitating tumor escape from immune system monitoring (20).